Researchers say they have identified the first genetic risk factors for fibromyalgia, offering compelling evidence that the chronic pain syndrome is fundamentally a disorder of the central nervous system.
The study, the largest of its kind, analysed genetic data from 11 international cohorts, including 54,629 individuals diagnosed with fibromyalgia and more than 2.5 million controls.
The researchers uncovered 26 genetic loci linked to fibromyalgia, providing the clearest biological basis yet for a condition long clouded by uncertainty and scepticism. Their findings are yet to be peer-reviewed by a journal but have been published as a pre-print on PubMed Central .
“This work provides the first robust genetic evidence defining fibromyalgia as a central nervous system disorder, thereby establishing a biological framework for its complex pathophysiology and extensive clinical comorbidities,” the researchers wrote.

